National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

VRC
 About the VRC
 Publications
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
 Research Areas


Vaccine Research Center (VRC)

Journal Publications, 2000

The NIH Library provides information about online journal access.

December

Trends in Microbiology
Viral replication and the coactivators p300 and CBP
Hottiger MO, Nabel GJ
Trends Microbiol. 8(12):560-565

November

Molecular Medicine
SM22a promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo
Akyurek LM, Yang Z-Y, Aoki K, San H, Nabel GJ, Parmacek MS, Nabel EG
Mol. Med. 6:983-991

Nature
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ.
Nature. 2000 Nov 30;408(6812):605-9.

Proceedings of the National Academy of Science U S A
Regulation of beta -catenin transformation by the p300 transcriptional coactivator
Sun Y, Kolligs FT, Hottiger MO, Mosavin R, Fearon ER, Nabel GJ.
Proceedings of the National Academy of Science U S A. 2000 Nov 7;97(23):12613-8.

October

European Journal of Clinical Investigation
N-acetylcysteine (NAC) replenishes glutathione in HIV infection
DeRosa, S. C., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Green, A., Mitra, D., Watanabe, N., Nakamura, H., Tjioe, I., Deresinski, S. C., Moore, W. A., Ela, S. W., Parks, D., Herzenberg, L. A. and Herzenberg, L. A. (2000).
Eur. J. Clin. Invest. 30, 915-29.

Science
Control of Viremia and prevention of clinical AIDS in Rhesus monkeys by cytokine-augmented DNA vaccination
Barouch DH, Santra S, Schmitz J, Kuroda M, Fu T, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka G, Beaudry K, Lifton M, Nickerson C, Trigona W, Punt K, Freed D, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom T, Gelman R, Montefiori D, Lewis M, Emini E, Shiver J, and Letvin N.
Science. 2000 Oct;290:486-492.

New England Journal of Medicine
Clinical implications of basic research: Antibodies and resistance to natural HIV infection
Nabel GJ and Sullivan NJ
N. Engl. J. Med. 343(17):1263-1265, 2000

September

Journal of Immunological Methods
A practical approach to multicolor flow cytometry for immunophenotyping
Baumgarth, N. and Roederer, M. (2000).
J. Immunol. Meth 243, 77-97.

August

Nature Medicine
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ.
Nature Medicine 2000 Aug;6(8):886-9.

June

Molecular Therapy
Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy
Aoki K, Akyurek LM, San H, Leung K, Parmacek MS, Nabel EG, Nabel GJ.
Molecular Therapy 2000 Jun;1(6):555-65

May

Circulation
Differential effects of the cyclin-dependent kinase inhibitors p27 (Kip1), p21 (Cip1), and p16 (Ink4) on vascular smooth muscle cell proliferation
Tanner FC, Boehm M, Akyürek LM, San H, Yang Z-Y, Tashiro J, Nabel GJ and Nabel EG
Circulation , 101(17):2022-2025

April

Human Gene Therapy
Human gene marker/therapy clinical protocols
Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson
JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Brenner M, Oldfield E,
Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K,
Heslop HE, Simons J, Wilmott RW, Boucher RC, Siegler HF, Barranger JA, Karlsson S, Kohn D,
Galpin JE, Raffel C, Hesdorffer C, Ilan J, Cassileth P, O'Shaughnessy J, Kun LE, Das TK, Wong
Staal F, Sobol RE, Haubrich R, Sznol M, Rubin J, Sorcher EJ, Rosenblatt J, Walker R, Brigham K,
Vogelzang N, Hersh E, Eck SL.
Hum. Gene Ther. 11(6):919-979

March

Journal of Immunotherapy
CD95-mediated tumor recognition by CD4+ effector cells in a murine mammary model
Aruga E, Tanigawa K, Aruga A, Arai H, Smith JW II, Nickoloff BJ, Nabel GJ, and Chang AE
J. Immunother. 23(2):225-34

February

Immunology Today
How much longer will tumour cells fool the immune system?
Ferrone S, Finerty JF, Jaffee EM, Nabel GJ.
Immunol. Today 21(2):70-72

January

Journal of Immunology
Ebola virus secretory glycoprotein (sGP) diminishes FcgammaRIIIB-to-CR3 proximity on neutrophils
J. Immunol. 164: 953-958

2000 Annual Review (Non-government)
HIV Molecular Immunology Database

Clinical Trials of HIV Vaccines in HIV Molecular Immunology Database Compendium
Graham BS, Korber BTM, Moore JP, Brander C, Walker BD, Haynes BF, Koup R, editors.
Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM, 2000, pages I-20 - I-38.

back to top


Highlights

The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges
May 16, 2007

Statement of Margaret I. Johnston, Ph.D., Gary J. Nabel, M.D., Ph.D., and Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day
May 14, 2007

Scientists Unveil Piece of HIV Protein that May Be Key to AIDS Vaccine Development
Feb. 14, 2007

Learn how to become a VRC Clinical Trials volunteer

 
E-mail Icon E-mail this page
Print Icon Print this page


Highlights

The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges
May 16, 2007

Statement of Margaret I. Johnston, Ph.D., Gary J. Nabel, M.D., Ph.D., and Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day
May 14, 2007

Scientists Unveil Piece of HIV Protein that May Be Key to AIDS Vaccine Development
Feb. 14, 2007

Learn how to become a VRC Clinical Trials volunteer